Evaluating exercise testing in patients with Peripheral Artery Disease
Official title: Sensitivity and Specificity of the AHA Post-exercise ABI Criteria
Run by Rennes University Hospital · NCT03186391 · Data updated 2026-11-12
This study is trying to see how exercise testing can help understand the challenges faced by people with Peripheral Artery Disease (PAD).
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Months and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 1 site (Rennes) |
| Status | Recruiting |
| Started | February 24, 2014 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | March 11, 2025 |
| Trial ID | NCT03186391 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who are referred to a vascular unit for evaluation of exercise limitations related to Peripheral Artery Disease.
✕Probably not a fit
Patients who are unable to walk on a treadmill or have severe cardiac conditions that contraindicate stress testing will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the effectiveness of exercise testing in patients suspected of having Peripheral Artery Disease (PAD). It is a non-interventional, prospective, cross-sectional study conducted at a single center, where data from patients referred to the vascular unit for exercise testing will be collected and analyzed. The study focuses on understanding exercise limitations in these patients to improve diagnostic and treatment approaches.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy and management strategies for patients with Peripheral Artery Disease.
How similar studies have gone: While this study is observational and focuses on exercise testing, similar approaches in evaluating exercise limitations in PAD have shown promise in improving patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients addressed in our vascular unit for exercise limitation Exclusion Criteria: * Incapacity to walk on the treadmill. * A severe cardiopathy contraindicating a stress test
Where it's running
-
Centre hospitalier Universitaire
Rennes, France Recruiting
Study contacts
- Principal investigator: Mahé Guillaume, MD-PhD — Rennes University Hospital
- Study coordinator: Mahé Guillaume, MD-PhD
- Email: guillaume.mahe@chu-rennes.fr
- Phone: 2 99 28 42 61
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events
In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.
-
Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD
This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.
-
Super-resolution ultrasound imaging for peripheral artery disease
This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.
-
Obstructive sleep apnea prevalence in people with peripheral artery disease
This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.
-
Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better
This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.
-
Evaluating a Paclitaxel Coated Balloon for Treating Atherosclerosis in Leg Arteries
This study is testing a special balloon treatment to see if it can safely improve blood flow and reduce symptoms in people with blocked leg arteries due to peripheral artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.